feed,title,long_url,short_url
MedRxiv,Effectiveness of a third dose of BNT162b2 or mRNA-1273 vaccine for preventing post-vaccination COVID-19 infection: an observational study,https://medrxiv.org/cgi/content/short/2021.11.29.21266777v1?rss=1,https://j.mp/3I5lDsV
MedRxiv,"Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike protein vaccine: a randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)",https://medrxiv.org/cgi/content/short/2021.11.30.21267047v1?rss=1,https://j.mp/3xF31er
